ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pre-Transplant Panel of Reactive T Cells (PRT) as an Independent Predictor of 2-Year Kidney Graft Function.

I. Gandolfini,1 E. Crespo,2 M. Baweja,1 U. Maggiore,3 P. Cravedi,1 P. Heeger,1 O. Bestard.2

1Icahn School of Medicine, New York, NY
2Bellvitge University Hospital, Barcelona, Spain
3University of Parma, Parma, Italy.

Meeting: 2016 American Transplant Congress

Abstract number: 209

Keywords: Graft function

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Kidney Immune Monitoring 2

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: Ballroom C

Related Abstracts
  • Donor-Reactive Alloantibodies Are the Dominant Effector Mechanism of Murine Kidney Allograft Rejection Induced by Memory CD4 T Cells
  • Overexpression of 2B4 Inhibits the Expansion and Function of Donor-Reactive CD8+ T Cells in Selective Lymphoid Compartments

Background: The ELISPOT PRT quantifies frequencies of IFN-g-producing effector/memory T cells reactive against a panel of allogenic stimulators. In contrast to the donor-reactive ELISPOT, it does not require donor cells and therefore can be performed also in cadaveric kidney recipients awaiting transplant. Addition of IL-15 to the assay uncovers reactivity of CD28neg memory CD8 T cells previously associated with increased risk of graft rejection (AJT 2014). Whether pre-transplant PRT+/-IL-15 is a biomarker of 2-y kidney graft function has not been carefully determined.

Methods: We performed PRT assays +/- IL-15 (IL-15 PRT) and anti-donor ELISPOT assays in 92 consecutive living (n=21) and cadaveric (n=71) kidney transplant recipients treated with thymoglobulin or basiliximab induction followed by CNI, MMF and early steroid withdrawal as maintenance. We used multivariable-regression repeated-measures linear mixed models to estimate the different time-change of eGFR between groups at 3, 6, 12, and 24-mo post-transplant, after adjusting for all potential confounders. A positive PRT was defined as >40 spots/10^5 cells against ≥50% of 8 donors (>80 spots with IL-15) based on Akaike information criterion. The threshold for positive anti-donor ELISPOT was 25 spots/2×10^5 cells, as per published studies.

Results: Absolute PRT values were highly correlated with IL-15 PRT (R:0.49; P<0.001), but there was no statistically significant correlation between PRT, or IL-15 PRT, and anti-donor ELISPOT. At baseline, 11 subjects were PRT+ (12%), [6 (7%) were IL-15 PRT+], and 61 subjects were anti-donor ELISPOT+ (66%). PRT-neg and IL-15 PRTneg subjects showed stable eGFR 3-24-mo post-transplant (-0.2mL/min, P=0.90 for PRTneg). In contrast PRT+ subjects had a significant eGFR decline (-12.8mL/mincompared with PRT-negative patients, P=0.003) [-15.2mL/min, P=0.002 with IL-15 PRT+]. Subjects positive for both PRT and anti-donor ELISPOT (N=8) had the lowest 3-mo and later eGFR (p=0.002) [P=0.012 with IL-15]. PRT levels were not associated with increased risk of AR, DGF, or histological lesions at 6-month per-protocol biopsy.

Conclusions: Pretransplant PRT and IL-15 PRT identify patients at risk for progressive graft loss independently from classic risk factors. Once validated in other cohorts, these findings will provide the rationale for using PRT screening to individualize immunosuppression.

CITATION INFORMATION: Gandolfini I, Crespo E, Baweja M, Maggiore U, Cravedi P, Heeger P, Bestard O. Pre-Transplant Panel of Reactive T Cells (PRT) as an Independent Predictor of 2-Year Kidney Graft Function. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gandolfini I, Crespo E, Baweja M, Maggiore U, Cravedi P, Heeger P, Bestard O. Pre-Transplant Panel of Reactive T Cells (PRT) as an Independent Predictor of 2-Year Kidney Graft Function. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/pre-transplant-panel-of-reactive-t-cells-prt-as-an-independent-predictor-of-2-year-kidney-graft-function/. Accessed March 5, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.